Finance entity
Every one of those 2 sits in a single category, markets. Of the tracked stories, 1 of 2 also mention Alphabet, the most common co-covered peer. Across a 17-day span, the pace is roughly 0.8 stories per week. Source depth averages 3 original sources per story, versus 2.3 across the same-window beat baseline.
Last mentioned: 6d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, markets. Of the tracked stories, 1 of 2 also mention Alphabet, the most common co-covered peer. Across a 17-day span, the pace is roughly 0.8 stories per week. Source depth averages 3 original sources per story, versus 2.3 across the same-window beat baseline. The 6.5 average consequence score is above the beat benchmark of 5.6 in the same window. This profile follows 2 Finance stories mentioning Novavax across the period from August 4, 2026 to August 20, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 471 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Novavax. Shared-story counts are live from our verified record — not editorial picks.
For finance readers, Aug. 19 was a case study in cross-asset relief: Treasury buyback news pulled the 30-year yield off its highest since 2007, feeding a 0.21% S&P 500 gain, while a more than 137% Moderna surge drove healthcare to a record 2.9% gain. The support for risk appetite masks a hawkish Fed minutes message and an unresolved long-term rate threat to AI-heavy valuations.
In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement.
Novavax is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
